Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $441,375 - $479,228
14,284 Added 36.16%
53,786 $1.7 Million
Q1 2022

May 16, 2022

SELL
$19.97 - $26.94 $242,835 - $327,590
-12,160 Reduced 23.54%
39,502 $1.03 Million
Q3 2021

Nov 15, 2021

SELL
$17.35 - $22.5 $65,322 - $84,712
-3,765 Reduced 6.79%
51,662 $993,000
Q2 2021

Aug 16, 2021

BUY
$18.01 - $28.32 $84,592 - $133,019
4,697 Added 9.26%
55,427 $1.23 Million
Q1 2021

May 14, 2021

BUY
$19.76 - $29.89 $44,815 - $67,790
2,268 Added 4.68%
50,730 $1.33 Million
Q4 2020

Mar 01, 2021

SELL
$15.73 - $21.66 $34,763 - $47,868
-2,210 Reduced 4.36%
48,462 $905,000
Q3 2020

Nov 13, 2020

BUY
$13.54 - $26.41 $52,751 - $102,893
3,896 Added 8.33%
50,672 $860,000
Q2 2020

Aug 14, 2020

SELL
$7.84 - $23.29 $22,453 - $66,702
-2,864 Reduced 5.77%
46,776 $1.09 Million
Q1 2020

May 15, 2020

BUY
$5.57 - $11.5 $61,715 - $127,420
11,080 Added 28.73%
49,640 $416,000
Q4 2019

Feb 14, 2020

SELL
$7.9 - $10.14 $69,180 - $88,795
-8,757 Reduced 18.51%
38,560 $376,000
Q3 2019

Nov 14, 2019

BUY
$9.17 - $12.01 $172,276 - $225,631
18,787 Added 65.85%
47,317 $449,000
Q2 2019

Aug 15, 2019

BUY
$10.88 - $17.6 $12,653 - $20,468
1,163 Added 4.25%
28,530 $0
Q1 2019

May 14, 2019

BUY
$15.51 - $17.61 $20,163 - $22,893
1,300 Added 4.99%
27,367 $0
Q4 2018

Feb 13, 2019

BUY
$14.52 - $19.72 $41,483 - $56,340
2,857 Added 12.31%
26,067 $452,000
Q3 2017

Nov 13, 2017

BUY
$13.45 - $14.35 $312,174 - $333,063
23,210
23,210 $0

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.